Approval · Notice of Compliance 9710 · 2008
DILAUDID: Notice of Compliance 9710
Issued August 8, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9710
- Date
- August 8, 2008
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Opioid analgesic
Products in this notice
Medicinal ingredients
- HYDROMORPHONE HCL 1 MG per TAB
- HYDROMORPHONE HCL 2 MG per TAB
- HYDROMORPHONE HCL 4 MG per TAB
- HYDROMORPHONE HCL 8 MG per TAB
- HYDROMORPHONE HCL 3 MG per SUP
- HYDROMORPHONE HCL 1 MG per ML
- HYDROMORPHONE HCL 2 MG per ML